Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125310721 | 12531072 | 1 | I | 20160630 | 20160706 | 20160706 | EXP | PHHY2016AR091618 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160706 | CN | COUNTRY NOT SPECIFIED | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125310721 | 12531072 | 1 | PS | DIOVAN D | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Unknown | 1 DF (VALSARTAN 160, HYDROCHLOROTHIAZIDE: STRENGTH AND UNITS NOT REPORTED) | U | 20818 | 1 | DF | |||||||
| 125310721 | 12531072 | 2 | SS | DIOVAN | VALSARTAN | 1 | Unknown | 80 OT, UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125310721 | 12531072 | 1 | Product used for unknown indication |
| 125310721 | 12531072 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125310721 | 12531072 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125310721 | 12531072 | General physical condition abnormal | |
| 125310721 | 12531072 | Glaucoma | |
| 125310721 | 12531072 | Limb discomfort | |
| 125310721 | 12531072 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |